cut

Dec. 23 (UPI) — At least four law officers were injured Tuesday in La Paz during clashes between marchers from the Central Obrera Boliviana, the country’s largest labor federation, and police as protests intensified over the government’s decision to end fuel subsidies.

President Rodrigo Paz issued a decree Dec. 18 eliminating fuel subsidies that had been in place for nearly 20 years. He also declared an “economic, financial and social emergency” to justify the reform and paired the measure with a 20% increase in the minimum wage to cushion its impact.

As a result of the decision, gasoline and diesel stopped being sold at state-controlled prices of about 53 cents per liter and shifted to prices reflecting the real cost of imports, leading to increases of nearly 200% for consumers.

According to reports by the Bolivian newspaper El Deber, the incidents that left police officers injured occurred near Plaza Murillo, close to the government palace, when miners and transport workers attempted to approach areas secured by law offivers.

The Ministry of Government said the injured officers were attacked with stones and blunt objects while carrying out public order duties.

Police said a miner was detained for allegedly throwing fireworks and dynamite. Labor leaders, meanwhile, criticized using tear gas to disperse demonstrators.

Union leaders warned that protests will continue unless their main demand is met — the repeal of the decree that eliminated fuel subsidies.

Bolivia’s Human Rights Ombudsman’s Office said that after the fuel price changes, fares for interdepartmental, interprovincial and urban transportation rose by as much as nearly 200% in several regions, according to La Razón.

After inspections at transport terminals and hubs in La Paz, Cochabamba and Santa Cruz, the ombudsman’s office documented widespread and unilateral fare hikes that in many cases doubled or even tripled prices, directly affecting the cost of living for Bolivian families.

El Deber reported that similar protests were recorded in Santa Cruz, including temporary road blockades and clashes with police, amid growing public anger over the impact of higher fuel prices on transportation and household expenses.

Authorities reiterated calls for dialogue and warned they will not tolerate violence, while unions said they will maintain mobilizations until the government reviews the measure.

United States President Donald Trump announced new agreements aimed at lowering prescription drug prices.

On Friday, alongside leaders from Bristol Myers Squibb, Gilead Sciences, and Merck, among other leading pharma giants, the president announced deals that would cut prices on their medications to match that of the developed nation with the lowest price.

“Starting next year, American drug prices will come down fast and furious and will soon be some of the lowest in the developed world,” Trump said.

“This is the biggest thing having to do with drugs in the history of the purchase of drugs.”

Under the deals, each drugmaker will cut prices on some of the drugs sold to the Medicaid programme for low-income people, senior administration officials said, promising “massive savings” on widely used medicines without giving specific figures.

“We were subsidising the entire world. We’re not doing it anymore,” Trump said at a White House news conference, flanked by nine pharma executives.

Mehmet Oz, the director of the Centres for Medicare and Medicaid Service, said Regeneron, Johnson & Johnson, and AbbVie would visit the White House after the holidays for the launch of the government’s TrumpRx website.

US patients currently pay by far the most for prescription medicines, often nearly three times more than in other developed nations, and Trump has been pressuring drugmakers to lower their prices to what patients pay elsewhere.

The details of each deal were not immediately available, but officials said they included agreements to cut cash-pay direct-to-consumer prices of select drugs sold potentially through the TrumpRx.gov website, to launch drugs in the US at prices equal to – not lower than – those in other wealthy nations and to increase manufacturing. In return, companies can receive a three-year exemption from any tariffs.

Drug prices fall

Merck said it will sell its diabetes drugs Januvia, Janumet and Janumet XR – set to face generic competition next year – directly to US consumers at about 70 percent off list prices. If approved, its experimental cholesterol drug enlicitide will also be offered through direct-to-consumer channels.

Enlicitide is one of two Merck drugs expected to receive a speedy review under the FDA’s new, fast-track pathway, the Reuters news agency has previously reported.

Amgen said it will expand its direct-to-patient programme to include migraine drug Aimovig and rheumatoid arthritis medicine Amjevita, offering both at $299 a month – nearly 60 percent and 80 percent below current US list prices.

In July, Trump sent letters to leaders of 17 major pharmaceutical companies, outlining how they should provide so-called most-favoured -nation prices to the US government’s Medicaid health programme for low-income people, and guarantee that new drugs will not be launched at prices above those in other high-income countries.

So far, five companies have struck deals with the administration to rein in prices. They are Pfizer, Eli Lilly, AstraZeneca, Novo Nordisk and EMD Serono, the US division of Germany’s Merck.

A portion of revenues from each company’s foreign sales will also be remitted to the US to offset costs, officials said.

The companies pledged together to invest more than $150bn in the US for R&D and manufacturing, according to officials, although it was unclear whether that included earlier commitments. Several also agreed to donate drug ingredients to the US strategic reserve.

Trump has long focused on the disparity between drug prices in the US and other wealthy countries, which have government-run health systems that negotiate price discounts.

The spectre of tighter price controls by the US government initially spooked investors, but the terms of the deals announced so far have calmed many of those fears.

Analysts have noted that Medicaid, which accounts for only approximately 10 percent of US drug spending, already benefits from substantial price discounts, exceeding 80 percent in some cases.

WASHINGTON — The U.S. Department of Health and Human Services on Thursday unveiled a series of regulatory actions designed to effectively ban gender-affirming care for minors, building on broader Trump administration restrictions on transgender Americans.

The sweeping proposals — the most significant moves this administration has taken so far to restrict the use of puberty blockers, hormone therapy and surgical interventions for transgender children — include cutting off federal Medicaid and Medicare funding from hospitals that provide gender-affirming care to children and prohibiting federal Medicaid dollars from being used to fund such procedures.

“This is not medicine, it is malpractice,” Health Secretary Robert F. Kennedy Jr. said of gender-affirming procedures on children in a news conference on Thursday. “Sex-rejecting procedures rob children of their futures.”

Kennedy also announced Thursday that the HHS Office of Civil Rights will propose a rule excluding gender dysphoria from the definition of a disability.

In a related move, the Food and Drug Administration issued warning letters to a dozen companies that market chest-binding vests and other equipment used by people with gender dysphoria. Manufacturers include GenderBender LLC of Carson, California and TomboyX of Seattle. The FDA letters state that chest binders can only be legally marketed for FDA-approved medical uses, such as recovery after mastectomy surgery.

Proposed rules would threaten youth gender-affirming care in states where it remains legal

Medicaid programs in slightly less than half of states currently cover gender-affirming care. At least 27 states have adopted laws restricting or banning the care. The Supreme Court’s recent decision upholding Tennessee’s ban means most other state laws are likely to remain in place.

Thursday’s announcements would imperil access in nearly two dozen states where drug treatments and surgical procedures remain legal and funded by Medicaid, which includes federal and state dollars.

The proposals announced by Kennedy and his deputies are not final or legally binding. The federal government must go through a lengthy rulemaking process, including periods of public comment and document rewrites, before the restrictions becoming permanent. They are also likely to face legal challenges.

But the proposed rules will likely further intimidate health care providers from offering gender-affirming care to children and many hospitals have already ceased such care in anticipation of federal action.

Nearly all U.S. hospitals participate in the Medicare and Medicaid programs, the federal government’s largest health plans that cover seniors, the disabled and low-income Americans. Losing access to those payments would imperil most U.S. hospitals and medical providers.

The same funding restrictions would apply to a smaller health program when it comes to care for people under the age of 19, the State Children’s Health Insurance Program, according to a federal notice posted Thursday morning.

Moves contradict advice from medical organizations and transgender advocates

Dr. Mehmet Oz, the administrator of the Centers for Medicare and Medicaid Services, on Thursday called transgender treatments “a Band-Aid on a much deeper pathology,” and suggested children with gender dysphoria are “confused, lost and need help.”

Polling shows many Americans agree with the administration’s view of the issue. An Associated Press-NORC Center for Public Affairs Research survey conducted earlier this year found that about half of U.S. adults approved of how Trump was handling transgender issues.

Chloe Cole, a conservative activist known for speaking about her gender-transition reversal, spoke at the news conference to express appreciation. She said cries for help from her and others in her situation, “have finally been heard.”

But the approach contradicts the recommendations of most major U.S. medical organizations, including the American Medical Association, which has urged states not to restrict care for gender dysphoria.

Advocates for transgender children strongly refuted the administration’s claims about gender-affirming care and said Thursday’s moves would put lives at risk.

“In an effort to strongarm hospitals into participating in the administration’s anti-LGBTQ agenda, the Trump Administration is forcing health care systems to choose between providing lifesaving care for LGBTQ+ young people and accepting crucial federal funding,” Dr. Jamila Perritt, a Washington-based OB/GYN and president and CEO of Physicians for Reproductive Health, said in a statement. “This is a lose-lose situation where lives are inevitably on the line. “

Rodrigo Heng-Lehtinen, senior vice president at The Trevor Project, a nonprofit suicide prevention organization for LBGTQ+ youth, called the changes a “one-size-fits-all mandate from the federal government” on a decision that should be between a doctor and patient.

“The multitude of efforts we are seeing from federal legislators to strip transgender and nonbinary youth of the health care they need is deeply troubling,” he said.

Actions build on a larger effort to restrict transgender rights

The announcements build on a wave of actions President Trump, his administration and Republicans in Congress have taken to target the rights of transgender people nationwide.

On his first day in office, Trump signed an executive order that declared the federal government would recognize only two immutable sexes: male and female. He also has signed orders aimed at cutting off federal support for gender transitions for people under age 19 and barring transgender athletes from participating in girls’ and women’s sports.

On Wednesday, a bill that would open transgender health care providers to prison time if they treat people under the age of 18 passed the U.S. House and heads to the Senate. Another bill under consideration in the House on Thursday aims to ban Medicaid coverage for gender-affirming care for children.

Young people who persistently identify as a gender that differs from their sex assigned at birth are first evaluated by a team of professionals. Some may try a social transition, involving changing a hairstyle or pronouns. Some may later also receive hormone-blocking drugs that delay puberty, followed by testosterone or estrogen to bring about the desired physical changes in patients. Surgery is rare for minors.

Swenson, Perrone and Shastri write for the Associated Press. Shastri reported from Milwaukee. AP writer Geoff Mulvihill contributed to this report.

A ceasefire deal appears distant as energy facilities are hit in Ukraine and Russia says a drone has killed two people.

Russian attacks have left thousands without power in Ukraine, while a drone attack killed two people in Russia, as United States-led peace talks on ending the war, deep in its fourth year, press on.

Ukrainian President Volodymyr Zelenskyy said Saturday that Russian night-time attacks damaged more than a dozen civilian facilities, disrupting power in seven regions.

“It is important that everyone now sees what Russia is doing… for this is clearly not about ending the war,” Zelenskyy said on social media. “They still aim to destroy our state and inflict maximum pain on our people.”

Kyiv and its Western allies have repeatedly said Russia is trying to cripple the Ukrainian power grid and deny civilians access to heat, light and running water for a fourth consecutive winter, in what Ukrainian officials call “weaponising” the cold.

Russian attacks left parts of the Kherson region, including the regional capital, Kherson, without power, according to regional head Oleksandr Prokudin.

Drone on Russia’s Saratov region

Russian authorities in the southwestern Saratov region, home to an important Russian army base, said a drone killed two people and damaged a residential building. Several windows were also blown out at a kindergarten and clinic.

Russia’s Ministry of Defence said it had shot down 41 Ukrainian drones over Russian territory overnight.

The latest round of attacks came after Kremlin adviser Yury Ushakov said on Friday that Russian police and National Guard will stay on in eastern Ukraine’s Donbas, which comprises the fiercely contested Donetsk and Luhansk regions, and oversee the industry-rich region, even if a peace settlement ends Russia’s nearly four-year war in Ukraine.

Ukraine has rejected Moscow’s demands to maintain its presence in Donbas post-war as US-led negotiations drag on.

Germany is set to host Zelenskyy on Monday for talks as peace efforts gain momentum and European leaders seek to steer negotiations. US negotiators have for months tried to navigate the demands of each side as US President Donald Trump presses for a swift end to Russia’s war.

The search for possible compromises has run into a major obstacle over who keeps Ukrainian territory currently occupied by Russian forces. Ukraine, the US and European powers are also still trying to outline the contours of security guarantees for Kyiv that could be accepted by Moscow.

In the absence of a breakthrough in negotiations to end the conflict, hostilities recently intensified in the Black Sea, with Russian forces attacking two Ukrainian ports and damaging three Turkish-owned vessels, including a ship carrying food supplies.

An attack on the city of Odesa on Friday caused grain silos to catch fire at the port, according to Ukrainian deputy prime minister and reconstruction minister, Oleksii Kuleba. Posting video footage on social media of firefighters tackling a blaze on board what he described as a “civilian vessel” in Chornomorsk, Zelenskyy said the Russian attacks “had no … military purpose whatsoever”.

Turkish President Recep Tayyip Erdogan on Saturday warned that the Black Sea should not turn into an “area of confrontation”.

“Everyone needs safe navigation in the Black Sea,” Erdogan said, calling for a “limited ceasefire” in attacks on ports and energy facilities. Turkiye controls the Bosphorus Strait, a key passage for transporting Ukrainian grain and Russian oil towards the Mediterranean.

A proposed tax increase in one European country has sparked concern

Ryanair has blasted moves that could see passengers pay higher bills under moves to increase airport departure taxes in one popular European destination by as much as double the current rate. In Belgium, the current federal tax stands at five euros per passenger and will be increased to 10 euros per passenger from 2027, which may see costs pushed onto passengers.

On top of this, Charleroi Airport in Belgium will reportedly make passengers spend three euros on their flights, according to proposals made by the Charleroi City Council. Some European publications have speculated this will push competition onto cheaper flights in neighbouring airports such as Paris-Beauvais and Lille Airport.

Ryanair are furious. In response to the proposed tax change, the airline has already confirmed this week that it will cut one million seats from its Brussels Winter 2026/27 schedule.

Ryanair said this move will also affect 20 routes on the schedule while arguing that the move is in direct opposition to other EU markets such as Slovakia, Sweden, Italy, and Hungary, where it claims such taxes are being cut down to drive up tourism. Because of this, Ryanair is calling on both the Belgian Prime Minister De Wever and the Mayor of Charleroi, Thomas Dermine, to reverse the proposed plans.

Ryanair’s Jason McGuinness said: “The De Wever Govt has bizarrely decided to further increase Belgium’s already sky-high aviation tax by another +100% from Jan 2027, on top of the +150% in July last. These repeated increases to this harmful aviation tax make Belgium completely uncompetitive compared to the many other EU countries, like Sweden, Hungary, Italy, and Slovakia, where Govts are abolishing aviation taxes to drive traffic, tourism, and jobs.

“As a result of this second tax hike in just 5 months, Ryanair has been forced to cut -22% of its Brussels traffic (-1m seats), -5 aircraft from our Charleroi base (loss of US$500m investment), and 20 routes (13 from Charleroi & 7 from Zaventem) for Winter 26/27. Should the Charleroi city council proceed with its ill-judged proposal to introduce further taxes on passengers departing from Charleroi next year, these cuts will deepen as Ryanair will be forced to reduce flights, routes and based aircraft at Charleroi from as early as April 2026 with thousands of local jobs at risk.

“If Prime Minister De Wever and his Govt really wanted to revive Belgium’s economy, they should abolish this harmful aviation tax, not double it. Despite so many other EU countries taking this step to support their economies, Belgium is going in the opposite direction, driving up access costs and pushing airlines and tourism elsewhere.

“We urge Prime Minister De Wever to scrap this damaging aviation tax before Belgian’s traffic, tourism, jobs, and the wider economy collapse any further. Furthermore, the Charleroi city council needs to abandon its lunatic plans to increase taxes driving job losses with the effect of lowering payroll, VAT and corporate tax receipts for the local economy.”

Belgium receives more than 18 million tourists each year. According to the latest data from the British government, around 1.3 million Brits travel to Belgium each year.

The proposed doubling is reportedly designed to help finance airport infrastructure and meet new environmental requirements, according to Air Journal.